| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328301 | Acta Haematologica Polonica | 2013 | 8 Pages |
Abstract
Introduction of new drugs into therapy of multiple myeloma prolonged significantly progression free survival and overall survival of patients. Taking into account pleiotropic effects of these drugs it was shown that immunomodulatory drugs are very effective in other haematological malignancies such as lymphomas, myelodysplastic syndromes, leukemias or chronic myeloproliferative diseases.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anna DmoszyÅska,